Systematic Evolution Of Ligands By Exponential Enrichment: Tissue Selex

Kirk Jensen (Inventor)

Research output: Patent

Abstract

This invention discloses high-affinity oligonucleotide ligands to complex tissue targets, specifically nucleic acid ligands having the ability to bind to complex tissue targets, and the methods for obtaining such ligands. Tissue targets comprise cells, subcellular components, aggregates or cells, collections of cells, and higher ordered structures. Specifically, nucleic acid ligands to red blood cells
ghosts, glioblastomas, and lymphomas are described.
LanguageEnglish
Patent numberAU 732961 B2
IPCAU 732961 B2
Publication statusPublished - 3 May 2001

Cite this

Jensen, K. (2001). IPC No. AU 732961 B2. Systematic Evolution Of Ligands By Exponential Enrichment: Tissue Selex. (Patent No. AU 732961 B2). Australian Patent Office.
Jensen, Kirk (Inventor). / Systematic Evolution Of Ligands By Exponential Enrichment: Tissue Selex. Australian Patent Office. IPC No.: AU 732961 B2. Patent No.: AU 732961 B2.
@misc{25300ae66d89435f9f55ba7f78e24a5a,
title = "Systematic Evolution Of Ligands By Exponential Enrichment: Tissue Selex",
abstract = "This invention discloses high-affinity oligonucleotide ligands to complex tissue targets, specifically nucleic acid ligands having the ability to bind to complex tissue targets, and the methods for obtaining such ligands. Tissue targets comprise cells, subcellular components, aggregates or cells, collections of cells, and higher ordered structures. Specifically, nucleic acid ligands to red blood cellsghosts, glioblastomas, and lymphomas are described.",
author = "Kirk Jensen",
year = "2001",
month = "5",
day = "3",
language = "English",
publisher = "Australian Patent Office",
type = "Patent",
note = "AU 732961 B2; AU 732961 B2",

}

Jensen, K 2001, Systematic Evolution Of Ligands By Exponential Enrichment: Tissue Selex, Patent No. AU 732961 B2, IPC No. AU 732961 B2.

Systematic Evolution Of Ligands By Exponential Enrichment: Tissue Selex. / Jensen, Kirk (Inventor).

Australian Patent Office. IPC No.: AU 732961 B2. Patent No.: AU 732961 B2.

Research output: Patent

TY - PAT

T1 - Systematic Evolution Of Ligands By Exponential Enrichment: Tissue Selex

AU - Jensen, Kirk

PY - 2001/5/3

Y1 - 2001/5/3

N2 - This invention discloses high-affinity oligonucleotide ligands to complex tissue targets, specifically nucleic acid ligands having the ability to bind to complex tissue targets, and the methods for obtaining such ligands. Tissue targets comprise cells, subcellular components, aggregates or cells, collections of cells, and higher ordered structures. Specifically, nucleic acid ligands to red blood cellsghosts, glioblastomas, and lymphomas are described.

AB - This invention discloses high-affinity oligonucleotide ligands to complex tissue targets, specifically nucleic acid ligands having the ability to bind to complex tissue targets, and the methods for obtaining such ligands. Tissue targets comprise cells, subcellular components, aggregates or cells, collections of cells, and higher ordered structures. Specifically, nucleic acid ligands to red blood cellsghosts, glioblastomas, and lymphomas are described.

M3 - Patent

M1 - AU 732961 B2

PB - Australian Patent Office

ER -